BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36163034)

  • 1. The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care.
    Saya S; Boyd L; Chondros P; McNamara M; King M; Milton S; Lourenco RA; Clark M; Fishman G; Marker J; Ostroff C; Allman R; Walter FM; Buchanan D; Winship I; McIntosh J; Macrae F; Jenkins M; Emery J
    Trials; 2022 Sep; 23(1):810. PubMed ID: 36163034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.
    Walker JG; Macrae F; Winship I; Oberoi J; Saya S; Milton S; Bickerstaffe A; Dowty JG; De Abreu Lourenço R; Clark M; Galloway L; Fishman G; Walter FM; Flander L; Chondros P; Ait Ouakrim D; Pirotta M; Trevena L; Jenkins MA; Emery JD
    Trials; 2018 Jul; 19(1):397. PubMed ID: 30045764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
    McIntosh JG; Emery JD; Wood A; Chondros P; Goodwin BC; Trevena J; Wilson C; Chang S; Hocking J; Campbell T; Macrae F; Milley K; Lew JB; Nightingale C; Dixon I; Castelli M; Lee N; Innes L; Jolley T; Fletcher S; Buchanan L; Doncovio S; Broun K; Austin G; Jiang J; Jenkins MA
    Trials; 2023 Nov; 24(1):723. PubMed ID: 37957680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening.
    Emery JD; Jenkins MA; Saya S; Chondros P; Oberoi J; Milton S; Novy K; Habgood E; Karnchanachari N; Pirotta M; Trevena L; Bickerstaffe A; De Abreu Lourenço R; Crothers A; Ouakrim DA; Flander L; Dowty JG; Walter FM; Clark M; Doncovio S; Etemadmoghadam D; Fishman G; Macrae F; Winship I; McIntosh JG
    Br J Gen Pract; 2023 Aug; 73(733):e556-e565. PubMed ID: 37012077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving adherence to surveillance and screening recommendations for people with colorectal cancer and their first degree relatives: a randomized controlled trial.
    Carey M; Sanson-Fisher R; Macrae F; Hill D; D'Este C; Paul C; Doran C
    BMC Cancer; 2012 Feb; 12():62. PubMed ID: 22314015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
    Wood A; Emery JD; Jenkins M; Chondros P; Campbell T; Wenkart E; O'Reilly C; Cowie T; Dixon I; Toner J; Khalajzadeh H; Gutierrez JM; Govan L; Buckle G; McIntosh JG
    Trials; 2022 Jan; 23(1):31. PubMed ID: 35022080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
    Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
    Trials; 2013 Jul; 14():239. PubMed ID: 23902589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of novel screening strategies for colorectal cancer screening in China (TARGET-C): a study protocol for a multicentre randomised controlled trial.
    Chen H; Li N; Shi J; Ren J; Liu C; Zhang Y; Jiang Z; Zhang Z; Dai M
    BMJ Open; 2019 Apr; 9(4):e025935. PubMed ID: 31005927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Genomic Test for Colorectal Cancer Risk: Is This Acceptable and Feasible in Primary Care?
    Saya S; McIntosh JG; Winship IM; Clendenning M; Milton S; Oberoi J; Dowty JG; Buchanan DD; Jenkins MA; Emery JD
    Public Health Genomics; 2020; 23(3-4):110-121. PubMed ID: 32688362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial.
    Dodd N; Carey M; Mansfield E; Oldmeadow C; Evans TJ
    Aust N Z J Public Health; 2019 Oct; 43(5):464-469. PubMed ID: 31268211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
    Steele RJC; Digby J; Chambers JA; O'Carroll RE
    BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of polygenic risk for personalised colorectal cancer screening.
    Frampton MJ; Law P; Litchfield K; Morris EJ; Kerr D; Turnbull C; Tomlinson IP; Houlston RS
    Ann Oncol; 2016 Mar; 27(3):429-34. PubMed ID: 26578737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three birds with one stone: a protocol for a randomised intervention study to increase participation in cervical and colorectal cancer screening among women attending breast cancer screening.
    Helgestad ADL; Larsen MB; Njor S; Tranberg M; Petersen LK; Andersen B
    BMJ Open; 2022 Sep; 12(9):e062824. PubMed ID: 36137619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial.
    Milton S; McIntosh J; Macrae F; Chondros P; Trevena L; Jenkins M; Walter FM; Taylor N; Boyd L; Saya S; Karnchanachari N; Novy K; Forbes C; Gutierrez JM; Broun K; Whitburn S; McGill S; Fishman G; Marker J; Shub M; Emery J
    Trials; 2021 Jul; 22(1):452. PubMed ID: 34266464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing the Effectiveness of a Primary Care Intervention to Improve Uptake of Colorectal Cancer Screening: A Randomized Controlled Trial Protocol.
    Dodd N; Carey ML; Mansfield E; Oldmeadow C
    JMIR Res Protoc; 2017 May; 6(5):e86. PubMed ID: 28490420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
    Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM
    BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial to evaluate the effectiveness and impact of offering postvisit decision support and assistance in obtaining physician-recommended colorectal cancer screening: the e-assist: Colon Health study-a protocol study.
    Lafata JE; Shin Y; Flocke SA; Hawley ST; Jones RM; Resnicow K; Schreiber M; Shires DA; Tu SP
    BMJ Open; 2019 Jan; 9(1):e023986. PubMed ID: 30617102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting colorectal cancer screening discussion: a randomized controlled trial.
    Christy SM; Perkins SM; Tong Y; Krier C; Champion VL; Skinner CS; Springston JK; Imperiale TF; Rawl SM
    Am J Prev Med; 2013 Apr; 44(4):325-329. PubMed ID: 23498096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients.
    Courtney RJ; Paul CL; Carey ML; Sanson-Fisher RW; Macrae FA; D'Este C; Hill D; Barker D; Simmons J
    BMC Cancer; 2013 Jan; 13():13. PubMed ID: 23305355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.